Psoriatic Arthritis is a chronic inflammatory disease that causes joint pain and swelling. It is commonly associated with psoriasis - an autoimmune disease affecting the skin and nails. Psoriatic Arthritis symptoms include swollen and tender joints, stiffness, pain, and reduced mobility. The disease impacts the peripheral joints of the body like those in fingers, wrists, ankles, knees, etc. Conventionally, non-steroidal anti-inflammatory drugs (NSAIDs) have been used to relieve pain and inflammation caused by psoriatic arthritis. 

However, the advent of biologic disease-modifying anti-rheumatic drugs (DMARDs) has revolutionized the Psoriatic Arthritis Treatment Market Demand of this condition. Biologic drugs selectively target specific components of the immune system to achieve better therapeutic outcomes.

The Global Psoriatic Arthritis Treatment Market is estimated to be valued at US$ 11.10 Bn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 To 2031.

Get More Insights On- Psoriatic Arthritis Treatment Market